Home/Co-Diagnostics/Dwight H. Egan
DH

Dwight H. Egan

Chief Executive Officer & Director

Co-Diagnostics

Therapeutic Areas

Co-Diagnostics Pipeline

DrugIndicationPhase
Logix Smart COVID-19 TestSARS-CoV-2 InfectionCommercial
Tuberculosis Detection & ResistanceMycobacterium tuberculosisCommercial/Development
Hepatitis B & C TestsHBV/HCV InfectionCommercial/Development
HPV TestHigh-risk Human PapillomavirusCommercial/Development
Malaria TestPlasmodium InfectionCommercial
Zika/Dengue/Chikungunya MultiplexArbovirus InfectionDevelopment
Respiratory Multiplex PanelsInfluenza, RSV, etc.Development